N

Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707

Watchlist Manager
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
SSE:603707
Watchlist
Price: 14 CNY -1.41% Market Closed
Market Cap: 22.6B CNY
Have any thoughts about
Nanjing King-friend Biochemical Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock under the Base Case scenario is 20.57 CNY. Compared to the current market price of 14 CNY, Nanjing King-friend Biochemical Pharmaceutical Co Ltd is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
20.57 CNY
Undervaluation 32%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation History
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Nanjing King-friend Biochemical Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Nanjing King-friend Biochemical Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Qualitative Analysis
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
CN
Pharmaceuticals
Market Cap
22.6B CNY
IPO
Jul 19, 2017
Employees
1 006
China
Market Cap
22.6B CNY
Industry
Pharmaceuticals
IPO
Jul 19, 2017
Loading...
Loading...
Loading...
Loading...
AI Assistant
AI Assistant
Ask me anything about Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

What unique competitive advantages
does Nanjing King-friend Biochemical Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Nanjing King-friend Biochemical Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide P/S
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide P/E
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide P/OCF
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide P/FCFE
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide P/B
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide EV/S
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide EV/GP
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide EV/EBIT
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide EV/OCF
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide EV/FCFF
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide EV/IC
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Show me price targets
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

What are the Net Income projections
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

What are the EPS projections
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

What are the EBIT projections
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nanjing King-friend Biochemical Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nanjing King-friend Biochemical Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nanjing King-friend Biochemical Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Nanjing King-friend Biochemical Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Nanjing King-friend Biochemical Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Nanjing King-friend Biochemical Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide ROE
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide ROA
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide ROIC
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide ROCE
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide Gross Margin
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide Operating Margin
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide Net Margin
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide FCF Margin
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Show all solvency ratios
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide D/E Ratio
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide D/A Ratio
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide Quick Ratio
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide Current Ratio
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Provide Cash Ratio
for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Current Assets 7.3B
Cash & Short-Term Investments 1.7B
Receivables 1.3B
Other Current Assets 4.3B
Non-Current Assets 2.4B
Long-Term Investments 72.8m
PP&E 1.5B
Intangibles 587.9m
Other Non-Current Assets 292.1m
Current Liabilities 3.1B
Accounts Payable 532.2m
Accrued Liabilities 127.6m
Short-Term Debt 1.7B
Other Current Liabilities 760.6m
Non-Current Liabilities 634m
Long-Term Debt 531.2m
Other Non-Current Liabilities 102.8m
Efficiency

Earnings Waterfall
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Revenue
3.9B CNY
Cost of Revenue
-2.3B CNY
Gross Profit
1.6B CNY
Operating Expenses
-2B CNY
Operating Income
-392m CNY
Other Expenses
-30.9m CNY
Net Income
-423m CNY

Free Cash Flow Analysis
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Nanjing King-friend Biochemical Pharmaceutical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional Revenue Growth Forecast
Negative Operating Income
51/100
Profitability
Score

Nanjing King-friend Biochemical Pharmaceutical Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Nanjing King-friend Biochemical Pharmaceutical Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
72/100
Solvency
Score

Nanjing King-friend Biochemical Pharmaceutical Co Ltd's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Nanjing King-friend Biochemical Pharmaceutical Co Ltd

Wall Street analysts forecast Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Nanjing King-friend Biochemical Pharmaceutical Co Ltd is 21.27 CNY with a low forecast of 21.06 CNY and a high forecast of 21.89 CNY.

Lowest
Price Target
21.06 CNY
50% Upside
Average
Price Target
21.27 CNY
52% Upside
Highest
Price Target
21.89 CNY
56% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Nanjing King-friend Biochemical Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Nanjing King-friend Biochemical Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock?

The intrinsic value of one Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock under the Base Case scenario is 20.57 CNY.

Is Nanjing King-friend Biochemical Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 14 CNY, Nanjing King-friend Biochemical Pharmaceutical Co Ltd is Undervalued by 32%.

Back to Top